Skip to content

Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses

Changes in Invitro and ex Vivo Lens Metrology With Experienced Daily Wear Contact Lens Wearers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01100411
Enrollment
35
Registered
2010-04-09
Start date
2010-03-31
Completion date
2010-07-31
Last updated
2012-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Contact lenses, myopia, lens geometry

Brief summary

The purpose of this study is to evaluate changes in contact lens geometry after lens wear

Detailed description

The purpose of this study is to evaluate changes invitro and ex vivo in contact lens geometry in daily lens wear

Interventions

Contact lens material: Lotrafilcon A

DEVICEBiofinity

Contact lens material: Comfilcon A

DEVICEProclear

Contact lens material: Omafilcon A

Contact lens material: Senofilcon A

DEVICEAcuvue 2

Contact lens material: Etafilcon A

DEVICEPurevision

Contact lens material: Balafilcon A

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent; * Be at least 18 years old; * Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator; * Have ocular health findings considered to be normal and which would not prevent the participant from safely wearing contact lenses; * Has vision correctable to at least 6/12 (20/40) or better at distance in each eye with contact lenses; * Be experienced at wearing contact lenses.

Exclusion criteria

* • Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses; * Any systemic disease that adversely affects ocular health * An active corneal infection or any active ocular disease that would affect wearing of contact lenses; * Use of any topical ocular medication during trial with the exception of saline drops ; * Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance * Eye surgery within 12 weeks immediately prior to enrolment for this trial; * Previous corneal refractive surgery; * Contraindications to contact lens wear; * Participated or currently enrolled in another clinical trial that may have affected vision or ocular physiology within the previous 2 weeks; * Be pregnant (formal testing of pregnancy is not required. A participant's verbal report is sufficient); * Worn soft contact lenses 2 calendar days or rigid gas permeable/ orthokeratology lenses 7 calendar days prior.

Design outcomes

Primary

MeasureTime frame
Lens Geometry1 week

Secondary

MeasureTime frameDescription
Corneal Shape1 week
Conjunctival Staining1 weekThe conjunctival staining

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026